Pravin Anand

Mr. Pravin Anand

Managing Partner
Anand and Anand

Pravin Anand, Managing Partner of Anand and Anand completed his law studies in New Delhi in 1979 and has been practicing as an advocate and as a patent and trademark attorney since. He has been a counsel in several landmark IP cases including: The first: Anton Piller Order (HMV cases); Mareva Injunction Order (Philips case); Norwich Pharmacal Order (Hollywood Cigarettes case); right of privacy case (Bandit Queen case); dilution in trademarks case (Glenfiddich case); recognition of market survey evidence by judiciary (the Time Warner case); domain name case (Yahoo! case); Punitive and Exemplary Damages (Time Magazine) Phishing (NASSCOM); the compulsory licensing cases filed against Pfizer and Roche under the Doha Declaration where both the innovator companies were successful and host of other cases which have transformed the IP land scape. He serves on the editorial board of several international IP journals including IP Asia, Entertainment Law Review and Computer & Telecommunications Law Review. He has authored several papers on IP, and written along with his co-author the two Intellectual Property Volumes on Halsbury's Laws of India. He has spoken extensively at various forums including WIPO, AIPPI, INTA, LES, IBA, LAW ASIA and the UN Conference on LDCs in the Digital World. He has served on several international and national expert groups and committees, including the patent law drafting committee for revising and recommending changes to law. He is the chairman of IPR Promotion Advisory Committee (IPAC) constituted by the government of India and the IT Committee set up by FICCI. He is the past president of the Asian Patent Attorneys Association (APAA India), He was the director on the Board of INTA in 2008. He is President of the AIPPI (Indian Group). he is most innovative lawyer -asia pacific. He has appeared as an expert witness before parliamentary committees to give evidence on amendments to trademark, patent and copyright laws

Friday, 26th March 2021

1:00 pm to 2:30 pm

Plenary II : Pharmaceutical Patent Rights VS Right to Health


Know More

Friday, 26th March 2021

4:30 pm to 6:00 pm

Plenary III : Impact of Covid 19 pandemic on innovation in business models, technologies and IP


Know More